Literature DB >> 1333922

A hereditary immunodeficiency characterized by CD8+ T lymphocyte deficiency and impaired lymphocyte activation.

W J Monafo1, S H Polmar, S Neudorf, A Mather, A H Filipovich.   

Abstract

An unusual form of severe combined immunodeficiency in children from two different families was associated with absence of CD8+ T lymphocytes and normal numbers of CD4+ T lymphocytes that did not respond to stimulation by non-specific mitogens, specific antibodies against T cell receptor or specific antigens. The defect in the CD4+ cells was bypassed by activating agents which are independent of the T cell receptor. The combination of an activation defect and selective depletion of CD8+ T lymphocytes suggests that the defective pathway is important in the differentiation of immature thymocytes as well as the proliferation of mature lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333922      PMCID: PMC1554576          DOI: 10.1111/j.1365-2249.1992.tb05856.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes.

Authors:  T Chatila; E Castigli; R Pahwa; S Pahwa; N Chirmule; N Oyaizu; R A Good; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 2.  T cell antigen receptor activation pathways: the tyrosine kinase connection.

Authors:  R D Klausner; L E Samelson
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

3.  Severe combined immunodeficiency due to a specific defect in the production of interleukin-2.

Authors:  K Weinberg; R Parkman
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

4.  Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.

Authors:  B H Koller; P Marrack; J W Kappler; O Smithies
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

Review 5.  The primary immunodeficiencies. (2).

Authors:  F S Rosen; M D Cooper; R J Wedgwood
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

6.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

7.  The CD4 molecule transmits biochemical information important in the regulation of T lymphocyte activity.

Authors:  S M Neudorf; M M Jones; B M McCarthy; J A Harmony; E M Choi
Journal:  Cell Immunol       Date:  1990-02       Impact factor: 4.868

8.  Abnormal lymphocyte capping in a patient with severe combined immunodeficiency disease.

Authors:  E W Gelfand; J M Oliver; R K Schuurman; D S Matheson; H M Dosch
Journal:  N Engl J Med       Date:  1979-12-06       Impact factor: 91.245

9.  Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage.

Authors:  E A Robey; B J Fowlkes; J W Gordon; D Kioussis; H von Boehmer; F Ramsdell; R Axel
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

10.  Coexistence of donor and host T lymphocytes following HLA-different bone marrow transplantation into a patient with cellular immunodeficiency and nonfunctional CD4+ T cells.

Authors:  C Knobloch; S F Goldmann; J Harpprecht; W Friedrich
Journal:  Transplantation       Date:  1991-09       Impact factor: 4.939

View more
  9 in total

Review 1.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

2.  Existence of activated and memory CD4+ T cells in peripheral blood and their skin infiltration in CD8 deficiency.

Authors:  K Katamura; G Tai; T Tachibana; H Yamabe; K Ohmori; M Mayumi; S Matsuda; S Koyasu; K Furusho
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.

Authors:  S Toyabe; A Watanabe; W Harada; T Karasawa; M Uchiyama
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

4.  Impaired immune function in children with Fanconi anaemia.

Authors:  Kasiani C Myers; Jack J Bleesing; Stella M Davies; Xue Zhang; Lisa J Martin; Robin Mueller; Richard E Harris; Alexandra H Filipovich; Melinda B Kovacic; Susanne I Wells; Parinda A Mehta
Journal:  Br J Haematol       Date:  2011-05-04       Impact factor: 6.998

5.  CD40 ligand deficiency: neurologic sequelae with radiographic correlation.

Authors:  Shrinivas Bishu; Deepak Madhavan; Phillip Perez; Lucy Civitello; Shuying Liu; Margaret Fessler; Steven M Holland; Ashish Jain; Maryland Pao
Journal:  Pediatr Neurol       Date:  2009-12       Impact factor: 3.372

6.  A novel Zap70 mutation with reduced protein stability demonstrates the rate-limiting threshold for Zap70 in T-cell receptor signalling.

Authors:  Bénédicte Cauwe; Lei Tian; Dean Franckaert; Wim Pierson; Kim A Staats; Susan M Schlenner; Adrian Liston
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

7.  Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.

Authors:  Geoffrey D E Cuvelier; Tamar S Rubin; Donna A Wall; Marlis L Schroeder
Journal:  J Clin Immunol       Date:  2016-07-20       Impact factor: 8.542

8.  Clinical, Immunological, and Genetic Features in 49 Patients With ZAP-70 Deficiency: A Systematic Review.

Authors:  Niusha Sharifinejad; Mahnaz Jamee; Majid Zaki-Dizaji; Bernice Lo; Mohammadreza Shaghaghi; Hamed Mohammadi; Farhad Jadidi-Niaragh; Shiva Shaghaghi; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

9.  Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency.

Authors:  Christina Gavino; Marija Landekic; Jibin Zeng; Ning Wu; Sungmi Jung; Ming-Chao Zhong; Alexis Cohen-Blanchet; Mélanie Langelier; Odile Neyret; Duncan Lejtenyi; Claudia Rochefort; Judith Cotton-Montpetit; Christine McCusker; Bruce Mazer; André Veillette; Donald C Vinh
Journal:  J Allergy Clin Immunol       Date:  2017-02-17       Impact factor: 10.793

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.